| Literature DB >> 35281354 |
Saurabh Trivedi1, Anand Sharma2, Kaushal Singh Baghel1, Sunaina Tejpal Karna1, Pooja Thaware1, Gaurav Trivedi3, Manvinder Tejpal4.
Abstract
Background: Intraoperative fluid strategy may affect the graft viability in head-and-neck surgeries with free flap reconstruction (HNS-FFR). Studies to guide regarding association of intraoperative fluid with metabolic parameters during such surgeries are infrequent. Aim: This study aimed to compare plasmalyte (PL) and normal saline (NS) (0.9%) in terms of acid-base balance and electrolytes in the peri-operative period along with graft viability during above-mentioned surgeries. Settings and Design: Prospective, observational cohort study was conducted in patients, 18-65 years, undergoing HNS-FFR at a tertiary care center. Materials andEntities:
Keywords: Head-and-neck surgery with free flap reconstruction; intraoperative fluid therapy; metabolic profile; normal saline; plasmalyte
Year: 2022 PMID: 35281354 PMCID: PMC8916140 DOI: 10.4103/aer.aer_133_21
Source DB: PubMed Journal: Anesth Essays Res ISSN: 2229-7685
Baseline characteristics of patients included in the study
| Parameter | Overall | Group A (PL) | Group B (NS) |
|
|---|---|---|---|---|
| Age (years)* | 50±11.64 | 51.5±12.1 | 46.5±13.7 | 0.105 |
| Gender (male/female) | 64/7 | 32/4 | 32/3 | 0.690 |
| Comorbidities | ||||
| Diabetes (%) | 31.4 | 25.7 | 31.4 | 0.303 |
| Hypertension (%) | 70 | 77.1 | 62.9 | 0.192 |
| Thyroid disorder (%) | 10 | 8.6 | 11.4 | 0.690 |
| CAD (%) | 7.1 | 11.4 | 2.9 | 0.164 |
*Mean±SD. P<0.05 is considered significant. CAD=Coronary artery disease, PL=Plasmalyte, NS=Normal saline, SD=Standard deviation
Descriptive statistics of patients for metabolic parameters, i.e., pH, base excess, and serum bicarbonate in Group A (plasmalyte) and Group B (normal saline)
| Group A-pH† | Group-pH† | Group A BE (mEq/L)† | Group B BE (mEq/L)† | Group A HCO3-(mEq/L)† | Group B HCO3-(mEq/L)† | ||||
|---|---|---|---|---|---|---|---|---|---|
| T1 | 7.38±0.05 | 7.37±0.04 | 0.213 | −0.94±2.44 | −1.61±2.15 | 0.230 | 23.63±2.26 | 22.99±1.99 | 0.216 |
| T2 | 7.39±0.05 | 7.36±0.04 | 0.056 | −1.40±2.32 | −2.27±2.11 | 0.103 | 23.07±2.28 | 22.20±2.09 | 0.099 |
| T3 | 7.37±0.06 | 7.33±0.04 | 0.014* | −2.57±2.52 | −3.80±2.52 | 0.045* | 21.88±2.52 | 20.96±2.33 | 0.116 |
| T4 | 7.35±0.07 | 7.31±0.05 | 0.013* | −3.13±3.20 | −5.45±2.93 | 0.002* | 21.38±3.12 | 19.51±2.76 | 0.010* |
| T5 | 7.36±0.06 | 7.35±0.06 | 0.265 | −2.67±2.83 | −3.99±2.84 | 0.056 | 21.87±2.84 | 20.67±2.79 | 0.079 |
| T6 | 7.37±0.06 | 7.36±0.06 | 0.459 | −2.11±2.41 | −2.60±2.99 | 0.446 | 22.54±2.21 | 21.86±2.86 | 0.270 |
| T7 | 7.38±0.05 | 7.37±0.05 | 0.184 | −1.23±1.98 | −1.79±2.07 | 0.249 | 22.67±4.32 | 22.63±1.89 | 0.966 |
*P<0.05 is considered significant, †Mean±SD. BE=Base excess, SD=Standard deviation, HCO3 −=Serum bicarbonate
Figure 1Comparison of pH between the study groups
Figure 2Comparison of base excess between the study groups
Descriptive statistics of patients for electrolytes, i.e., serum sodium, serum potassium, and serum chloride in Group A (plasmalyte) and Group B (normal saline)
| Na+ (mEq/L) | K+ (mEq/L) | Cl- (mEq/L) | |||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
| |||||||
| Group A† | Group B† |
| Group A† | Group B† |
| Group A† | Group B† |
| |
| T1 | 134.47±4.66 | 132.6±4.92 | 0.107 | 4.03±0.43 | 3.95±0.49 | 0.452 | 105.20±6.23 | 104.14±5.36 | 0.450 |
| T2 | 133.68±3.67 | 132.94±4.13 | 0.321 | 4.16±0.64 | 4.05±0.50 | 0.419 | 106.26±5.60 | 105.69±5.17 | 0.659 |
| T3 | 134.74±3.62 | 133.81±4.90 | 0.308 | 4.11±0.52 | 4.20±0.58 | 0.482 | 106.77±4.74 | 107.69±4.64 | 0.418 |
| T4 | 135.63±3.57 | 134.81±4.90 | 0.426 | 4.19±0.58 | 4.30±0.65 | 0.476 | 106.97±4.71 | 108.60±5.52 | 0.189 |
| T5 | 135.74±3.18 | 136.65±3.35 | 0.250 | 4.15±0.66 | 4.10±0.60 | 0.737 | 106.83±4.85 | 108.00±4.75 | 0.311 |
| T6 | 136.98±3.46 | 137.17±3.45 | 0.812 | 4.08±0.52 | 3.88±0.52 | 0.103 | 107.0±3.96 | 107.25±4.82 | 0.814 |
| T7 | 137.52±3.21 | 137.40±3.69 | 0.885 | 3.94±0.57 | 3.96±0.48 | 0.843 | 106.29±5.05 | 105.20±5.36 | 0.386 |
P<0.05 is considered significant, †Mean±SD. SD=Standard deviation, Na+=Serum sodium, K+=Serum potassium, HCO3 −=Serum bicarbonate, Cl−=Serum chloride
Descriptive statistics of patients for total crystalloid used intraoperatively, urine output intra- and postoperatively, intraoperative phenylephrine used, intensive care unit stay, and hospital stay in Group A (plasmalyte) and Group B (normal saline)
| Group | Mean±SD | ||
|---|---|---|---|
| Intraoperative total crystalloid used (mL) | A-PL | 3445.71±588.79 | 0.322 |
| B-NS | 3565.71±632.89 | ||
| Intraoperative urine output (mL) | A-PL | 952.86±263.45 | 0.194 |
| B-NS | 875.43±303.88 | ||
| Urine output POD 1 (mL) | A-PL | 1858.97±581.73 | 0.765 |
| B-NS | 1824.85±338.83 | ||
| Urine output POD 2 (mL) | A-PL | 1299.57±371.74 | 0.316 |
| B-NS | 1391.60±389.68 | ||
| Urine output POD 3 (mL) | A-PL | 1026.29±243.28 | 0.250 |
| B-NS | 1093.43±241.29 | ||
| Intraoperative total phenylephrine used (mg) | A-PL | 0.950±0.398 | 0.012* |
| B-NS | 1.139±1.185 | ||
| ICU stay (days) | A-PL | 2.09±0.288 | 0.326 |
| B-NS | 2.06±0.236 | ||
| Hospital stay (days) | A-PL | 7.09±0.288 | 0.942 |
| B-NS | 7.09±0.284 |
*P<0.05 is considered significant. POD=Postoperative day, SD=Standard deviation, ICU=Intensive care unit, PL=Plasmalyte, NS=Normal saline